Monday, July 18, 2016

Teva Pharm prices $15 bln in notes to fund Allergan generics deal

TEL AVIV, July 19 (Reuters) - Teva Pharmaceutical Industries

Ltd said on Tuesday it successfully priced a debt

offering for $15 billion worth of senior notes to help fund its

acquisition of Allergan...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)